Literature DB >> 1955186

Prognostic indicators for invasive carcinoma of the vulva.

F N Rutledge1, M F Mitchell, M F Munsell, E N Atkinson, S Bass, V McGuffee, E Silva.   

Abstract

Three hundred sixty-five patients with invasive squamous cell carcinoma of the vulva have been treated at M.D. Anderson Cancer Center between 1944 and 1990. We undertook a rigorous review of the medical records, and a Cox proportional hazards model was applied to examine predictors of both failure to survive and recurrence. Significant predictors of both failure to survive and recurrence included tumor size, clinical stage, therapy aim, pelvic or inguinal nodal metastases, and positive margins. We then undertook an analysis of Stage I and II lesions treated with a curative aim to see if there was a difference in survival or in disease-free interval between those patients treated with radical vulvectomy and those treated with radical wide local excision. There was no survival advantage from the radical vulvectomy procedure. We conclude that careful selection may allow us to choose some patients for less radical procedures.

Entities:  

Mesh:

Year:  1991        PMID: 1955186     DOI: 10.1016/0090-8258(91)90352-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis.

Authors:  R Holm; S Knopp; Z Suo; C Tropè; J M Nesland
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

2.  False positive PET-CT scan and clinical examination in a patient with locally advanced vulvar cancer.

Authors:  Latoya J Perry; Onur Guralp; Ahmed Al-Niaimi; Noah A Zucker; David M Kushner
Journal:  Gynecol Oncol Case Rep       Date:  2013-01-06

3.  Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence.

Authors:  Alejandro M Aragona; Alejandro H Soderini; Nicasio A Cuneo
Journal:  J Gynecol Oncol       Date:  2014-07-06       Impact factor: 4.401

Review 4.  Vulvar carcinoma: dilemma, debates, and decisions.

Authors:  Swarupa Mitra; Manoj Kumar Sharma; Inderjeet Kaur; Ruparna Khurana; Kanika Batra Modi; Raman Narang; Avik Mandal; Soumya Dutta
Journal:  Cancer Manag Res       Date:  2018-01-09       Impact factor: 3.989

5.  The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva.

Authors:  Ellen L Barlow; Neil Lambie; Mark W Donoghoe; Zin Naing; Neville F Hacker
Journal:  J Oncol       Date:  2020-03-24       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.